Ultimately, synapses are considered the pathway for the spreading of tau pathology in AD3, hence a better understanding of how synapses and synaptic changes contribute to this process will be critical to develop targeted therapies for attenuating tau spreading to prevent downstream neurodegeneration and cognitive decline. This evidence concerns the gene MAPT and Mental deterioration.